Cullinan Oncology Inc. (CGEM) PT Lowered to $38 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Jeffrey Hung lowered the price target on Cullinan Oncology Inc. (NASDAQ: CGEM) to $38.00 (from $40.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
